EN | UA
EN | UA

Help Support

Back

Labetalol found safer and more tolerable than Nifedipine in preeclampsia

Preeclampsia Preeclampsia
Preeclampsia Preeclampsia

What's new?

Labetalol stands out as the prime and safe choice for managing hypertension in pregnancy, minimizing risks for both mother and baby.

Even though Labetalol and Nifedipine were found to be equally effective in Preeclampsia, however, Labetalol outshined Nifedipine in terms of better tolerability and side effects profile in a recent study. 

This prospective interventional study published in the Journal of Clinical & Diagnostic Research aimed to distinguish between Labetalol and Nifedipine administration concerning the side effects, obstetric complications and mode of administration.

A total of 200 pregnant Indian women with high blood pressure or hypertension after 20 weeks of gestation were considered. They were grouped as: 

  • Group A - 100 Women administered Labetalol with the majority of cases needing a 200 mg dose, followed by a 300 mg dose 
  • Group B - 100 Women administered Nifedipine with the majority of cases needing a 30 mg dose, followed by 20 mg and 40 mg dose

Their age, associated-side effects, pregnancy complications and mode of delivery (vaginal or caesarean) were compared. The details of study outcomes have been differentiated in the following table 1:

The outcomes between Group A and Group B did not vary significantly and were found to be equally effective, concluded the study researchers.

Source:

Journal of Clinical & Diagnostic Research

Article:

Comparison of the Efficacy of Labetalol and Nifedipine in Preeclampsia: A Prospective Interventional Study.

Authors:

Neha Nimbark et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try: